The relationship between cardiovascular xerogenic medication intake and the incidence of crown/root restorations

Gerardo Maupomé, Dawn Peters, William A. Rush, D. Brad Rindal, B. Alex White

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objectives: This retrospective, longitudinal cohort study quantified the strength of the association between xerogenic cardiovascular medication use and dental restorations, using the latter as a proxy measure for dental caries experience. Methods: Study data were collected from 11 years of electronic clinical/pharmacy records in two large dental group practices associated with managed care organizations (MCO). Records were extracted for all members who were at least 55 years old at the end of the 11 year window, and had at least 48 months of concurrent dental, medical, and pharmacy coverage. The authors identified 4,448 individuals whose only xerogenic medication exposure was to drugs treating a cardiovascular condition. This group was compared to a group not taking any medications (n-1,183), and a group taking medications with no known xerostomic side effect (n-5,622). Poisson regression compared restoration incidence and mean restoration rates among the three groups. Results: MCO members taking cardiovascular or non-xerogenic medications had higher restoration incidence and mean restoration rates than individuals taking no medications. A small difference in mean restoration rate between the non-xerogenic medication group and the cardiovascular drug group was observed; no significant difference in restoration incidence was seen between these two groups. Conclusions: This study provides objective quantification of cardiovascular medication's long-term effects on increased restorations in older adults. When grouped under a single category labeled "cardiovascular, " drugs with effects targeting the cardiovascular system did not appear to unequivocally lead to higher restorative experiences.

Original languageEnglish (US)
Pages (from-to)49-56
Number of pages8
JournalJournal of Public Health Dentistry
Volume66
Issue number1
DOIs
StatePublished - 2006

Fingerprint

Crowns
Cardiovascular Agents
Managed Care Programs
Dental Group Practices
Incidence
Tooth
Organizations
Dental Caries
Proxy
Cardiovascular System
Longitudinal Studies
Cohort Studies
Pharmaceutical Preparations

Keywords

  • Cardiovascular
  • Cardiovascular drugs
  • Caries
  • Incidence
  • Rates
  • Restorations
  • Xerostomia

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

The relationship between cardiovascular xerogenic medication intake and the incidence of crown/root restorations. / Maupomé, Gerardo; Peters, Dawn; Rush, William A.; Rindal, D. Brad; White, B. Alex.

In: Journal of Public Health Dentistry, Vol. 66, No. 1, 2006, p. 49-56.

Research output: Contribution to journalArticle

Maupomé, Gerardo ; Peters, Dawn ; Rush, William A. ; Rindal, D. Brad ; White, B. Alex. / The relationship between cardiovascular xerogenic medication intake and the incidence of crown/root restorations. In: Journal of Public Health Dentistry. 2006 ; Vol. 66, No. 1. pp. 49-56.
@article{e5800d7630b145ccafd83da109b879d9,
title = "The relationship between cardiovascular xerogenic medication intake and the incidence of crown/root restorations",
abstract = "Objectives: This retrospective, longitudinal cohort study quantified the strength of the association between xerogenic cardiovascular medication use and dental restorations, using the latter as a proxy measure for dental caries experience. Methods: Study data were collected from 11 years of electronic clinical/pharmacy records in two large dental group practices associated with managed care organizations (MCO). Records were extracted for all members who were at least 55 years old at the end of the 11 year window, and had at least 48 months of concurrent dental, medical, and pharmacy coverage. The authors identified 4,448 individuals whose only xerogenic medication exposure was to drugs treating a cardiovascular condition. This group was compared to a group not taking any medications (n-1,183), and a group taking medications with no known xerostomic side effect (n-5,622). Poisson regression compared restoration incidence and mean restoration rates among the three groups. Results: MCO members taking cardiovascular or non-xerogenic medications had higher restoration incidence and mean restoration rates than individuals taking no medications. A small difference in mean restoration rate between the non-xerogenic medication group and the cardiovascular drug group was observed; no significant difference in restoration incidence was seen between these two groups. Conclusions: This study provides objective quantification of cardiovascular medication's long-term effects on increased restorations in older adults. When grouped under a single category labeled {"}cardiovascular, {"} drugs with effects targeting the cardiovascular system did not appear to unequivocally lead to higher restorative experiences.",
keywords = "Cardiovascular, Cardiovascular drugs, Caries, Incidence, Rates, Restorations, Xerostomia",
author = "Gerardo Maupom{\'e} and Dawn Peters and Rush, {William A.} and Rindal, {D. Brad} and White, {B. Alex}",
year = "2006",
doi = "10.1111/j.1752-7325.2006.tb02551.x",
language = "English (US)",
volume = "66",
pages = "49--56",
journal = "Journal of Public Health Dentistry",
issn = "0022-4006",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - The relationship between cardiovascular xerogenic medication intake and the incidence of crown/root restorations

AU - Maupomé, Gerardo

AU - Peters, Dawn

AU - Rush, William A.

AU - Rindal, D. Brad

AU - White, B. Alex

PY - 2006

Y1 - 2006

N2 - Objectives: This retrospective, longitudinal cohort study quantified the strength of the association between xerogenic cardiovascular medication use and dental restorations, using the latter as a proxy measure for dental caries experience. Methods: Study data were collected from 11 years of electronic clinical/pharmacy records in two large dental group practices associated with managed care organizations (MCO). Records were extracted for all members who were at least 55 years old at the end of the 11 year window, and had at least 48 months of concurrent dental, medical, and pharmacy coverage. The authors identified 4,448 individuals whose only xerogenic medication exposure was to drugs treating a cardiovascular condition. This group was compared to a group not taking any medications (n-1,183), and a group taking medications with no known xerostomic side effect (n-5,622). Poisson regression compared restoration incidence and mean restoration rates among the three groups. Results: MCO members taking cardiovascular or non-xerogenic medications had higher restoration incidence and mean restoration rates than individuals taking no medications. A small difference in mean restoration rate between the non-xerogenic medication group and the cardiovascular drug group was observed; no significant difference in restoration incidence was seen between these two groups. Conclusions: This study provides objective quantification of cardiovascular medication's long-term effects on increased restorations in older adults. When grouped under a single category labeled "cardiovascular, " drugs with effects targeting the cardiovascular system did not appear to unequivocally lead to higher restorative experiences.

AB - Objectives: This retrospective, longitudinal cohort study quantified the strength of the association between xerogenic cardiovascular medication use and dental restorations, using the latter as a proxy measure for dental caries experience. Methods: Study data were collected from 11 years of electronic clinical/pharmacy records in two large dental group practices associated with managed care organizations (MCO). Records were extracted for all members who were at least 55 years old at the end of the 11 year window, and had at least 48 months of concurrent dental, medical, and pharmacy coverage. The authors identified 4,448 individuals whose only xerogenic medication exposure was to drugs treating a cardiovascular condition. This group was compared to a group not taking any medications (n-1,183), and a group taking medications with no known xerostomic side effect (n-5,622). Poisson regression compared restoration incidence and mean restoration rates among the three groups. Results: MCO members taking cardiovascular or non-xerogenic medications had higher restoration incidence and mean restoration rates than individuals taking no medications. A small difference in mean restoration rate between the non-xerogenic medication group and the cardiovascular drug group was observed; no significant difference in restoration incidence was seen between these two groups. Conclusions: This study provides objective quantification of cardiovascular medication's long-term effects on increased restorations in older adults. When grouped under a single category labeled "cardiovascular, " drugs with effects targeting the cardiovascular system did not appear to unequivocally lead to higher restorative experiences.

KW - Cardiovascular

KW - Cardiovascular drugs

KW - Caries

KW - Incidence

KW - Rates

KW - Restorations

KW - Xerostomia

UR - http://www.scopus.com/inward/record.url?scp=33646197112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646197112&partnerID=8YFLogxK

U2 - 10.1111/j.1752-7325.2006.tb02551.x

DO - 10.1111/j.1752-7325.2006.tb02551.x

M3 - Article

C2 - 16570751

AN - SCOPUS:33646197112

VL - 66

SP - 49

EP - 56

JO - Journal of Public Health Dentistry

JF - Journal of Public Health Dentistry

SN - 0022-4006

IS - 1

ER -